Reinhardt M - Search Results

1

[Effectiveness of syringe shieldings using radionuclides in radiation synovectomy].

Rödel R, Ebert A, Reichmann K, Reinhardt M, Palmedo H, Biersack HJ, von Mallek D. Rödel R, et al. Among authors: reinhardt m. Nuklearmedizin. 2003 Feb;42(1):50-3. Nuklearmedizin. 2003. PMID: 12601455 German.

2

Long term changes in serum T4, T3, and TSH in benign thyroid disease: proof of a narrow individual variation.

Biersack HJ, Hartmann F, Rödel R, Reinhardt M. Biersack HJ, et al. Among authors: reinhardt m. Nuklearmedizin. 2004 Oct;43(5):158-60; quiz 162-3. doi: 10.1267/nukl04050158. Nuklearmedizin. 2004. PMID: 15480504

3

Breast cancer imaging with PET and SPECT agents: an in vivo comparison.

Palmedo H, Hensel J, Reinhardt M, Von Mallek D, Matthies A, Biersack HJ. Palmedo H, et al. Among authors: reinhardt m. Nucl Med Biol. 2002 Nov;29(8):809-15. doi: 10.1016/s0969-8051(02)00342-6. Nucl Med Biol. 2002. PMID: 12453590

4

Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.

Reinhardt MJ, Joe A, von Mallek D, Zimmerlin M, Manka-Waluch A, Palmedo H, Krause TM. Reinhardt MJ, et al. Eur J Nucl Med Mol Imaging. 2002 Apr;29(4):480-5. doi: 10.1007/s00259-001-0722-0. Epub 2002 Jan 29. Eur J Nucl Med Mol Imaging. 2002. PMID: 11914885 Clinical Trial.

5

Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome.

Reinhardt MJ, Brink I, Joe AY, Von Mallek D, Ezziddin S, Palmedo H, Krause TM. Reinhardt MJ, et al. Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1118-24. doi: 10.1007/s00259-002-0877-3. Epub 2002 Jun 26. Eur J Nucl Med Mol Imaging. 2002. PMID: 12192554 Clinical Trial.

6

Value of tumour marker S-100B in melanoma patients: a comparison to 18F-FDG PET and clinical data.

Reinhardt MJ, Kensy J, Frohmann JP, Willkomm P, Reinhold U, Grünwald F, Biersack HJ, Bender H. Reinhardt MJ, et al. Nuklearmedizin. 2002 Jun;41(3):143-7. Nuklearmedizin. 2002. PMID: 12109034

7

[Detection of impaired renal function: is the modern serologic marker cystatin C more accurate than the 99mTc-MAG3 clearance?].

Reinhardt MJ, Weidling H, Breuel HP, Biersack HJ. Reinhardt MJ, et al. Nuklearmedizin. 2004 Dec;43(6):203-9. doi: 10.1267/nukl04060203. Nuklearmedizin. 2004. PMID: 15586216 German.

8

[Technical limits of PET/CT with 18FDG in prostate cancer].

von Mallek D, Backhaus B, Müller SC, Matthies A, Palmedo H, Jaeger U, Biersack HJ, Reinhardt M. von Mallek D, et al. Among authors: reinhardt m. Aktuelle Urol. 2006 May;37(3):218-21. doi: 10.1055/s-2006-932129. Aktuelle Urol. 2006. PMID: 16733826 German.

9

PET-imaging in tumors of the reproductive trac.

Reinhardt MJ, Matthies A, Biersack HJ. Reinhardt MJ, et al. Q J Nucl Med. 2002 Jun;46(2):105-12. Q J Nucl Med. 2002. PMID: 12114873 Review.

10

[PET/CT imaging in head and neck tumors].

Rödel R, Straehler-Pohl HJ, Palmedo H, Reichmann K, Jaeger U, Reinhardt MJ, Biersack HJ. Rödel R, et al. Among authors: reinhardt mj. Radiologe. 2004 Nov;44(11):1055-9. doi: 10.1007/s00117-004-1125-6. Radiologe. 2004. PMID: 15517137 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters